From October 15 to 17, the HI Japan 2025 Health Ingredients Exhibition was grandly held in Tokyo. As a pioneer in the NMN industry and a globally leading biotechnology company, Bontac was invited to participate, s
From October 15 to 17, the HI Japan 2025 Health Ingredients Exhibition was grandly held in Tokyo. As a pioneer in the NMN industry and a globally leading biotechnology company, Bontac was invited to participate, s
On October 20, 2025, the Shenzhen SME Service Bureau announced the list of the seventh batch of "Little Giant" enterprises and the 2025 re-evaluated enterprises. Bontac, with its outstanding comprehensive stre
Global population aging is becoming increasingly pronounced. It is estimated that by 2050, the number of people aged 65 and above will reach 1.6 billion—double the 780 million recorded in 2020. As aging progresses,
A brand-new authoritative study is here! A 2025 experiment by the Northwest A&F University team, published in the Journal of Microbiology (Core Journal, DOI: 10.13343/j.cnki.wsxb.20250174), revealed with rigorous dat
September 29, 2025 — After nearly three years of pressure from the Natural Products Association (NPA), the U.S. Food and Drug Administration (FDA) has reversed course and confirmed that Beta (β) Nicotinamide M
In recent years, “N-series” anti-aging dietary supplements represented by NMN and NR have continued to gain popularity in markets across Europe, the U.S., Japan, and China. The core mechanism of these product
In the world of nutrition, some substances have existed for over a hundred years but have only recently been recognized for their great value. Ergothioneine (EGT) is such a modest yet precious dietary component. △ Ch
According to the latest research published in authoritative journals such as *Nature Metabolism*, human metabolomics data show non-linear dramatic changes between the ages of 30 and 50. These include lipid metabolism imb
On August 5, Bontac NR Hydrogen Malate product successfully obtained a patent certificate issued by the United States Patent and Trademark Office (USPTO) (Publication No.: US12378279B2), marking another authoritativ